Breaking

Precious Metals Price Update: Gold, Silver, PGMs Volatile on Oil Spike, Fed Rates
Uranium Supply Behind, Demand Evolving — What’s Next? Denison Mines’ David Cates
Additional Strong Assays Results Extend High-Grade Antimony Mineralisation at Oaky Creek
Jeffrey Christian: Gold, Silver Prices to Rise, Risk Highest Since WWII
Uranium Market Facing Supply Crunch as Nuclear Fleet Grows
Syntholene Selects Papadakis Engineering as Integration Partner for Novel Thermal-Hybrid Synthetic Fuel Demonstration Facility Heat Exchanger System
Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit
Lahontan Announces Private Placement

Business
Investing
Stocks
World
Search for:

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Additional Strong Assays Results Extend High-Grade Antimony Mineralisation at Oaky Creek

Uranium Supply Behind, Demand Evolving — What’s Next? Denison Mines’ David Cates

Precious Metals Price Update: Gold, Silver, PGMs Volatile on Oil Spike, Fed Rates

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (530)
- Investing (2,973)
- Stocks (963)
- World (1,481)

Disclaimer: owninnervoice.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2026 owninnervoice.com | All Rights Reserved

Top

Business
Investing
Stocks
World

Type above and press Enter to search. Press Esc to cancel.